A nniversaries offer opportunities to commemorate crucial discoveries of modern medicine, such as vaccination (May 14, 1796), ether (October 16, 1846), and insulin (January 11, 1922) . But zeroing in on specific dates can obscure important dynamics. Innovation in medicine is a complex and continuous process that generally can't be pinned down to a single moment in time.
The history of coronary-artery bypass grafting (CABG) demonstrates the subtleties of medical innovation well. Fifty years ago, on May 9, 1967, Cleveland Clinic surgeon René Favaloro performed his first CABG procedure. By 1970, he and his colleagues -who are often credited with having "revolutionized the treatment of ischemic heart disease" 1 -had performed more than 1000 such operations. Impressed by their results, surgeons throughout the United States adopted the technique. But although Favaloro's work popularized CABG, he was not the first to perform the operation. Moreover, he quickly modified his initial approach, and surgeons have been continually modifying the operation ever since (see diagram). CABG, like all significant medical interventions, is the product of innumerable innovations by many physicians.
The idea behind CABG had actually been around for decades. In 1910, Alexis Carrel published an account of an operation he'd performed on a dog: he used a segment of carotid artery to connect the descending aorta to the left coronary artery. 1, 2 If the initial idea were the key aspect of innovation, Carrel would be considered the inventor of CABG. Yet he reported only a single, unsuccessful attempt: ventricular fibrillation developed, and the dog died. Carrel concluded that the procedure would succeed only if a surgeon could complete the anastomoses in less than 3 minutes, something that was beyond even his prodigious surgical skill.
Discouraged by Carrel's experience, surgeons tried other approaches to tackling coronary disease over the next 50 years. 1, 2 Some reduced cardiac workload by means of thyroidectomy or sympathectomy. Others tried to increase blood supply to the myocardium by dusting the heart with asbestos to induce vascular adhesions, suturing omentum onto the heart, ligating or implanting the internal thoracic artery, or ligating the coronary sinus.
Yet CABG was not forgotten. In the 1940s and 1950s, Toronto surgeon Gordon Murray conducted experiments in animals. He excised coronary segments, inserted interposition grafts, and placed bypass grafts from various arteries. Unfortunately, ventricular fibrillation and graft thrombosis occurred frequently. Moscow surgeon Vladimir Demikhov also experimented with coronary bypass grafts, successfully anastomosing the internal thoracic artery in dogs in July 1953. 3 Michael DeBakey surveyed the field in 1964 and found 12 or 14 laboratories working on coronary-artery bypass.
He didn't think their techniques, whose average success rate was just 50%, were ready for use in humans. 2 Nevertheless, surgeons had begun trying. 1, 2 In May 1960, German emigré Robert Goetz anastomosed the right internal thoracic artery onto the right coronary artery of a patient at Van Etten Hospital in the Bronx. 4 In 1962, David Sabiston used a saphenous vein graft to create a bypass from a patient's ascending aorta to the right coronary artery. Leningrad Most of these surgeons had setbacks. Goetz's colleagues considered the operation "not only highly experimental, but also unwarranted" and prevented him from performing a second bypass. 4 Sabiston became discouraged after his patient died from a postoperative stroke. Garrett and DeBakey's patient had a perioperative infarction. One of Longmire's patients died during the surgery; the other one's graft failed. Only Kolesov pursued a long case series.
If the credit for a procedure belongs to the surgeon who first operated on a human patient, then Goetz wins the prize. He was The surgery depicted involves a saphenous-vein graft from the aorta to the right coronary artery (RCA), an in situ graft from the left internal thoracic artery (LITA) to the left anterior descending coronary artery (LAD), a composite right-internal-thoracic-artery (RITA) graft from the LITA graft to the circumflex coronary artery, and a radial-artery graft from the aorta to the diagonal coronary artery. American surgeons adopted the operation enthusiastically. They were performing more than 100,000 CABG procedures per year by 1977, and more than 600,000 by 1997. CABG also provided a crucial precedent for coronary angioplasty, which was first described by Andreas Grüntzig in 1977.
Surgeons continued refining CABG. They tested various conduits, including the gastroepiploicartery and radial-artery autografts. They learned to place multiple grafts to provide more complete revascularization. They expanded the clinical indications for the procedure: Kolesov performed a CABG for acute myocardial infarction in February 1968, and Favaloro did the same that April. 1 Technical innovations improved clinical outcomes and reduced complication rates. Beating-heart CABG and minimally invasive procedures became popular in the 1990s, though these haven't replaced traditional approaches. New diagnostic techniques (e.g., intravascular ultrasonography and measurement of fractional flow reserve) allow refined selection of patients. Physicians and patients can now choose hybrid procedures with a combination of angioplasty, stents, and bypass grafts. Biomedical engineers are working to develop synthetic vascular grafts. Even as CABG and angioplasty grow increasingly sophisticated, physicians recognize that the ideal approach to coronary disease is prevention -yet people in whom disease develops still need to be treated.
With every innovation came demands that surgeons submit their techniques to the rigorous standards of the emerging field of evidence-based medicine. CABG was one of the first major operations subjected to a randomized, controlled trial. The results of the first such trial, the Veterans Administration Cooperative Study, were published in the Journal in September 1977. Scores of others have followed.
In 1989, the Society of Thoracic Surgeons established a national cardiac surgery registry, which facilitates ongoing quality-improvement efforts. The same year, New York State began public reporting of cardiac surgery outcomes. These efforts have made CABG perhaps the most thoroughly examined operation in the surgical repertoire. Cardiac surgeons and cardiologists now collaborate on heart teams to provide the best data to their patients for shared decision making.
Coronary revascularization, now representing a major sector of the health care economy, has relieved angina in countless patients and extended many lives. The Favaloro anniversary honors one moment in the continuing evolution of the procedure -a multifaceted process of social and scientific innovation that continues today.
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